vs
LIGHTPATH TECHNOLOGIES INC（LPTH）与Sanara MedTech Inc.（SMTI）财务数据对比。点击上方公司名可切换其他公司
Sanara MedTech Inc.的季度营收约是LIGHTPATH TECHNOLOGIES INC的1.7倍（$27.5M vs $16.4M），Sanara MedTech Inc.净利率更高（-5.9% vs -57.5%，领先51.7%），LIGHTPATH TECHNOLOGIES INC同比增速更快（120.2% vs 4.6%），Sanara MedTech Inc.自由现金流更多（$3.9M vs $2.0M），过去两年LIGHTPATH TECHNOLOGIES INC的营收复合增速更高（45.7% vs 21.8%）
LightPath Technologies Inc是一家精密光学组件及组件生产商，主营非球面透镜、红外光学器件、光纤产品等，服务工业自动化、航空航天、国防、医疗成像、电信等领域的全球客户，提供标准及定制化光学解决方案。
Sanara MedTech Inc.是一家总部位于美国的医疗科技企业，专注于研发、生产和销售外科手术、伤口护理、康复期护理类创新医疗产品，主要服务北美地区的医院、医疗机构及长期护理场所，旗下多款产品获FDA认证，旨在提升患者护理效果并降低医疗运营成本。
LPTH vs SMTI — 直观对比
营收规模更大
SMTI
是对方的1.7倍
$16.4M
营收增速更快
LPTH
高出115.6%
4.6%
净利率更高
SMTI
高出51.7%
-57.5%
自由现金流更多
SMTI
多$1.9M
$2.0M
两年增速更快
LPTH
近两年复合增速
21.8%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.4M | $27.5M |
| 净利润 | $-9.4M | $-1.6M |
| 毛利率 | 36.8% | 93.2% |
| 营业利润率 | -52.6% | 23.5% |
| 净利率 | -57.5% | -5.9% |
| 营收同比 | 120.2% | 4.6% |
| 净利润同比 | -260.1% | 5.3% |
| 每股收益（稀释后） | $-0.20 | $-0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LPTHSMTI
| Q4 25 | $16.4M | $27.5M | ||
| Q3 25 | $15.1M | $26.3M | ||
| Q2 25 | $12.2M | $25.8M | ||
| Q1 25 | $9.2M | $23.4M | ||
| Q4 24 | $7.4M | $26.3M | ||
| Q3 24 | $8.4M | $21.7M | ||
| Q2 24 | $8.6M | $20.2M | ||
| Q1 24 | $7.7M | $18.5M |
净利润LPTHSMTI
| Q4 25 | $-9.4M | $-1.6M | ||
| Q3 25 | $-2.9M | $-30.4M | ||
| Q2 25 | $-7.1M | $-2.0M | ||
| Q1 25 | $-3.6M | $-3.5M | ||
| Q4 24 | $-2.6M | $-1.7M | ||
| Q3 24 | $-1.6M | $-2.9M | ||
| Q2 24 | $-2.4M | $-3.5M | ||
| Q1 24 | $-2.6M | $-1.8M |
毛利率LPTHSMTI
| Q4 25 | 36.8% | 93.2% | ||
| Q3 25 | 29.8% | 92.9% | ||
| Q2 25 | 22.0% | 92.5% | ||
| Q1 25 | 29.1% | 92.2% | ||
| Q4 24 | 26.0% | 91.4% | ||
| Q3 24 | 33.9% | 90.8% | ||
| Q2 24 | 29.2% | 90.0% | ||
| Q1 24 | 20.9% | 89.8% |
营业利润率LPTHSMTI
| Q4 25 | -52.6% | 23.5% | ||
| Q3 25 | -16.6% | 11.2% | ||
| Q2 25 | -38.0% | -0.1% | ||
| Q1 25 | -36.3% | -8.9% | ||
| Q4 24 | -33.5% | 18.6% | ||
| Q3 24 | -16.4% | 3.6% | ||
| Q2 24 | -25.6% | -14.3% | ||
| Q1 24 | -33.6% | -8.3% |
净利率LPTHSMTI
| Q4 25 | -57.5% | -5.9% | ||
| Q3 25 | -19.2% | -115.5% | ||
| Q2 25 | -57.8% | -7.8% | ||
| Q1 25 | -39.1% | -15.1% | ||
| Q4 24 | -35.2% | -6.5% | ||
| Q3 24 | -19.3% | -13.2% | ||
| Q2 24 | -27.3% | -17.4% | ||
| Q1 24 | -33.7% | -9.5% |
每股收益（稀释后）LPTHSMTI
| Q4 25 | $-0.20 | $-0.32 | ||
| Q3 25 | $-0.07 | $-3.40 | ||
| Q2 25 | $0.19 | $-0.23 | ||
| Q1 25 | $-0.44 | $-0.41 | ||
| Q4 24 | $-0.07 | $-0.18 | ||
| Q3 24 | $-0.04 | $-0.34 | ||
| Q2 24 | $-0.15 | $-0.41 | ||
| Q1 24 | $-0.07 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $73.6M | $16.6M |
| 总债务越低越好 | — | $46.0M |
| 股东权益账面价值 | $77.9M | $5.9M |
| 总资产 | $148.6M | $72.9M |
| 负债/权益比越低杠杆越低 | — | 7.74× |
8季度趋势，按日历期对齐
现金及短期投资LPTHSMTI
| Q4 25 | $73.6M | $16.6M | ||
| Q3 25 | — | $14.9M | ||
| Q2 25 | $4.9M | $17.0M | ||
| Q1 25 | — | $20.7M | ||
| Q4 24 | — | $15.9M | ||
| Q3 24 | — | $16.3M | ||
| Q2 24 | — | $6.2M | ||
| Q1 24 | — | $2.8M |
总债务LPTHSMTI
| Q4 25 | — | $46.0M | ||
| Q3 25 | — | $45.1M | ||
| Q2 25 | — | $44.2M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $30.7M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | $535.0K | $14.4M | ||
| Q1 24 | $599.4K | $9.7M |
股东权益LPTHSMTI
| Q4 25 | $77.9M | $5.9M | ||
| Q3 25 | $21.4M | $6.1M | ||
| Q2 25 | $15.6M | $35.4M | ||
| Q1 25 | $15.7M | $36.7M | ||
| Q4 24 | $26.7M | $39.4M | ||
| Q3 24 | $29.4M | $39.8M | ||
| Q2 24 | $30.2M | $41.7M | ||
| Q1 24 | $31.7M | $43.3M |
总资产LPTHSMTI
| Q4 25 | $148.6M | $72.9M | ||
| Q3 25 | $87.3M | $71.1M | ||
| Q2 25 | $81.5M | $98.8M | ||
| Q1 25 | $81.4M | $96.4M | ||
| Q4 24 | $45.8M | $88.1M | ||
| Q3 24 | $48.4M | $88.5M | ||
| Q2 24 | $48.1M | $73.4M | ||
| Q1 24 | $49.7M | $70.9M |
负债/权益比LPTHSMTI
| Q4 25 | — | 7.74× | ||
| Q3 25 | — | 7.33× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 1.18× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | 0.76× | ||
| Q2 24 | 0.02× | 0.34× | ||
| Q1 24 | 0.02× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.8M | $3.9M |
| 自由现金流经营现金流 - 资本支出 | $2.0M | $3.9M |
| 自由现金流率自由现金流/营收 | 12.0% | 14.0% |
| 资本支出强度资本支出/营收 | 5.3% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-6.3M | $2.2M |
8季度趋势，按日历期对齐
经营现金流LPTHSMTI
| Q4 25 | $2.8M | $3.9M | ||
| Q3 25 | $-1.1M | $2.2M | ||
| Q2 25 | $-2.6M | $2.7M | ||
| Q1 25 | $-3.2M | $-2.0M | ||
| Q4 24 | $-737.4K | $932.0K | ||
| Q3 24 | $-1.7M | $2.1M | ||
| Q2 24 | $64.7K | $-1.4M | ||
| Q1 24 | $-394.2K | $-1.6M |
自由现金流LPTHSMTI
| Q4 25 | $2.0M | $3.9M | ||
| Q3 25 | $-1.2M | $1.1M | ||
| Q2 25 | $-3.3M | $902.7K | ||
| Q1 25 | $-3.7M | $-3.7M | ||
| Q4 24 | $-817.8K | $859.9K | ||
| Q3 24 | $-1.8M | $2.0M | ||
| Q2 24 | $-225.5K | $-1.5M | ||
| Q1 24 | $-802.5K | $-1.7M |
自由现金流率LPTHSMTI
| Q4 25 | 12.0% | 14.0% | ||
| Q3 25 | -8.1% | 4.2% | ||
| Q2 25 | -27.3% | 3.5% | ||
| Q1 25 | -40.0% | -15.9% | ||
| Q4 24 | -11.0% | 3.3% | ||
| Q3 24 | -21.2% | 9.4% | ||
| Q2 24 | -2.6% | -7.3% | ||
| Q1 24 | -10.4% | -9.0% |
资本支出强度LPTHSMTI
| Q4 25 | 5.3% | 0.3% | ||
| Q3 25 | 0.5% | 4.0% | ||
| Q2 25 | 5.6% | 6.8% | ||
| Q1 25 | 4.6% | 7.4% | ||
| Q4 24 | 1.1% | 0.3% | ||
| Q3 24 | 0.9% | 0.0% | ||
| Q2 24 | 3.4% | 0.3% | ||
| Q1 24 | 5.3% | 0.4% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LPTH
| Other | $7.9M | 48% |
| Infrared Components | $5.0M | 31% |
| Visible Components | $3.4M | 21% |
SMTI
| Soft Tissue Repair Products | $24.7M | 90% |
| Bone Fusion Products | $2.8M | 10% |
